Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Sanara (SMTI)

Biological agents for the therapy of severe tissue damage have become firmly established in surgical practice, guaranteeing stable demand for Sanara MedTech Inc. (SMTI) products. Current price action based on the EV/EBITDA multiple is 23.18, while the company retains leading specialists through prestige and lucrative compensation packages. Growth prospects rely on the commercial launch of new matrices and the integration of digital services into medicine.

Sanara MedTech, Inc. - Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan SMTI (periode 23.11.2025 - 12.11.2026)

Rincian analitis perusahaan Sanara MedTech Inc.

- rega pasar lan target rega analis:

Bagan rega Sanara MedTech|SMTI - Target median analis

- rincian kapitalisasi pasar:

Nilai pasar Sanara MedTech Inc.|SMTI - Nilai Perusahaan

- indikator nilai buku ekuitas:

Nilai Buku saben Saham Sanara MedTech|SMTI - Pambiji Buku Bisnis|Rasio Nilai Pasar marang Nilai Buku sanaramedtech.com|SMTI - Total Aset Bisnis

- indikator beban kredit lan likuiditas emiten:

Utang marang Ekuitas Sanara MedTech Inc.|SMTI - Rasio tanggungan utang jangka dawa marang modal|Utang jangka cendhak marang modal Sanara MedTech|SMTI - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Sanara MedTech Inc.|SMTI - Tanggungan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Sanara MedTech|Likuiditas cepet sanaramedtech.com

- rincian asil keuangan lan kelipatan valuasi:

SMTI - Bathi pungkasan|Proyeksi bathi mangsa ngarep Sanara MedTech Inc.|SMTI - Pangali P/E|Prakiraan rega marang bathi Sanara MedTech|SMTI - Koefisien bali modal nimbang wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Sanara MedTech Inc.|SMTI - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) Sanara MedTech|SMTI - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi EPS kuartalan sanaramedtech.com|SMTI - Wutah bathi saben saham ing taun iki|Prakiraan wutah bathi saben saham kanggo taun ngarep Sanara MedTech Inc.

Analisis fundamental perusahaan:SMTI (Sanara)

The EV/EBITDA multiple compares the total enterprise value of Sanara MedTech Inc. (SMTI) with its operating profit before depreciation, taxes, and interest. This metric allows for an assessment of the business's real value by neutralizing the impact of debt load and tax regimes. Stable demand for medical innovations makes such calculations a reliable analytical tool for this defensive asset. The EV/EBITDA trajectory of Sanara MedTech Inc. (SMTI) helps identify fundamental undervaluation or the risk of stagnant earnings in a timely manner.

Analisis pesaing Sanara MedTech Inc.